Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Capital Employed (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Return on Capital Employed for 4 consecutive years, with 1.69% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 335.0% year-over-year to 1.69%, compared with a TTM value of 1.69% through Sep 2025, down 335.0%, and an annual FY2024 reading of 30.6%, down 2845.0% over the prior year.
  • Return on Capital Employed was 1.69% for Q3 2025 at Atara Biotherapeutics, up from 0.23% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 25.62% in Q2 2024 and bottomed at 7.9% in Q4 2023.
  • Average Return on Capital Employed over 4 years is 3.63%, with a median of 0.06% recorded in 2025.
  • The sharpest move saw Return on Capital Employed skyrocketed 2715bps in 2024, then tumbled -2539bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.96% in 2022, then plummeted by -727bps to 7.9% in 2023, then skyrocketed by 222bps to 9.62% in 2024, then tumbled by -82bps to 1.69% in 2025.
  • Business Quant data shows Return on Capital Employed for ATRA at 1.69% in Q3 2025, 0.23% in Q2 2025, and 0.36% in Q1 2025.